Core Viewpoint - Wanze Co., Ltd. has been recognized with two prestigious awards, "Annual Private Leading Brand" and "Classic Brand Case," at the 2025 Ninth China Listed Company Brand Value List Conference, highlighting its brand strength, innovation, and industry influence [1][2]. Group 1: Company Overview - Wanze Co., Ltd. is a leading player in the pharmaceutical micro-ecology field and one of the few private enterprises in China capable of full-process research and development from high-temperature alloy materials to component manufacturing [1][2]. - The company’s subsidiary, Inner Mongolia Shuangqi, is the only national high-tech enterprise focused on digestive and gynecological micro-ecological systems, with its core products "Jin Shuangqi®" and "Ding Junsheng®" leading their respective markets [2]. Group 2: Financial Performance - In 2024, Wanze Co., Ltd. achieved a revenue of 1.079 billion yuan, a year-on-year increase of 9.93%, and a net profit attributable to shareholders of 193 million yuan, up 9.17% [3]. - For Q1 2025, the company reported a revenue of 335 million yuan and a net profit of approximately 72.69 million yuan, reflecting year-on-year growth rates of 15.34% and 10.52%, respectively [3]. Group 3: Research and Development - In 2024, Wanze Co., Ltd. invested 209 million yuan in R&D for high-temperature alloys, marking a significant increase of 27.48% year-on-year [5]. - The company has established a research team with a high proportion of master's and doctoral graduates, enhancing its capabilities in aerospace engine material research [5]. Group 4: Future Strategy - The company aims to enhance its R&D, production, and market expansion efforts, focusing on micro-ecology and high-temperature alloys to create greater shareholder value and contribute to industry development [6].